Family Office Of America (FOFA) Change in Accured Expenses (2021 - 2026)
Family Office Of America (FOFA) posted Change in Accured Expenses of -$73710.0 for Q1 2026, down 793.74% sequentially from $10625.0 in Q3 2025, and down 1462.73% YoY from $5409.0 in Q1 2025.
Family Office Of America (FOFA) Change in Accured Expenses (2021 - 2026) Analysis & Trends
Family Office Of America has reported Change in Accured Expenses for 6 years, with the latest figure at -$73710.0 in Q1 2026.
- Quarterly Change in Accured Expenses fell 1462.73% year-over-year to -$73710.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$78591.0 (down 532.58% YoY) and the FY2025 annual result came in at $528.0, down 96.9% from the prior year.
- Change in Accured Expenses retreated to -$73710.0 in Q1 2026 per FOFA's latest filing, from $10625.0 in the prior quarter.
- Over five years, Change in Accured Expenses peaked at $11052.0 in Q3 2024 and troughed at -$73710.0 in Q1 2026.
- A 5-year average of -$8427.2 and a median of -$2361.0 in 2024 frame the typical range for Change in Accured Expenses.
- The sharpest annual moves came in 2024 and 2026: Change in Accured Expenses jumped 182.69% in 2024, then slumped 1462.73% in 2026.
- Over 5 years, Change in Accured Expenses stood at -$14689.0 in 2022, then advanced by 26.22% to -$10838.0 in 2023, then soared by 137.53% to $4068.0 in 2024, then soared by 161.18% to $10625.0 in 2025, then slumped by 793.74% to -$73710.0 in 2026.
- According to Business Quant data, Change in Accured Expenses over the past three periods registered -$73710.0, $10625.0, and -$15506.0 for Q1 2026, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | - |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 298.00 Mn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 123.00 Mn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 234.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 123.70 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 112.90 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 19.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 43.01 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 4.80 Mn |
| 10 | Family Office Of America | 27.84 Mn | 27.20 Mn | 532,674.00 | 86,895.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -73,710.00 |
| Mar 31, 2026 | -73,710.00 |
| Sep 30, 2025 | 10,625.00 |
| Sep 30, 2025 | 10,625.00 |
| Jun 30, 2025 | -15,506.00 |
| Jun 30, 2025 | -15,506.00 |
| Mar 31, 2025 | 5,409.00 |
| Mar 31, 2025 | 5,409.00 |
| Dec 31, 2024 | 4,068.00 |
| Dec 31, 2024 | 4,068.00 |
| Sep 30, 2024 | 11,052.00 |
| Sep 30, 2024 | 11,052.00 |
| Jun 30, 2024 | -2,361.00 |
| Jun 30, 2024 | -2,361.00 |
| Mar 31, 2024 | 4,300.00 |
| Mar 31, 2024 | 4,300.00 |
| Dec 31, 2023 | -10,838.00 |
| Dec 31, 2023 | -10,838.00 |
| Sep 30, 2023 | -13,366.00 |
| Sep 30, 2023 | -13,366.00 |